Recently, Eclipse treatment planning system (TPS) version 8.8 was upgraded to the latest version 13.6. It is customary that the vendor gives training on how to upgrade the existing software to the new version. However, the customer is provided less inner details about changes in the new software version. According to manufacturer, accuracy of point dose calculations and irregular treatment planning is better in the new version (13.6) compared to the old version (8.8). Furthermore, the new version uses voxel-based calculations while the earlier version used point dose calculations. Major difference in intensity-modulated radiation therapy (IMRT) plans was observed between the two versions after re-optimization and re-calculations. However, minor difference was observed for IMRT cases after performing only re-calculations. It is recommended TPS quality assurance to be performed after any major upgrade of software. This can be done by performing dose calculation comparisons in TPS. To assess the difference between the versions, 25 clinical cases from the old version were compared keeping all the patient data intact including the monitor units and comparing the differences in dose calculations using dose volume histogram (DVH) analysis. Along with DVH analysis, uniformity index, conformity index, homogeneity index, and dose spillage index were also compared for both versions. The results of comparative study are presented in this paper.

The aim of the present study was to investigate the dose-volume variations of planning target volume (PTV) and organs at risks (OARs) in 15 left lung cancer patients comparing analytical anisotropic algorithm (AAA) versus Acuros XB algorithm. Originally, all plans were created using AAA with a template of dose constraints and optimization parameters, and the patients were treated using intensity modulated radiotherapy. In addition, another set of plans was created by performing only dose calculations using Acuros algorithm without doing any reoptimization. Thereby, in both set of plans, the entire plan parameters, namely, beam angle, beam weight, number of beams, prescribed dose, normalization point, region of interest constraints, number of monitor units, and plan optimization were kept constant. The evaluated plan parameters were PTV coverage at dose at 95% volume (TV95) of PTV (D95), the dose at 5% of PTV (D5), maximum dose (Dmax), the mean dose (Dmean), the percent volume receiving 5 Gy (V5), 20 Gy (V20), 30 Gy (V30) of normal lung at risk (left lung- gross target volume [GTV], the dose at 33% volume (D33), at 67% volume (D67), and the Dmean (Gy) of the heart, the Dmax of the spinal cord. Furthermore, homogeneity index (HI) and conformity index were evaluated to check the quality of the plans. Significant statistical differences between the two algorithms, P < 0.05, were found in D95, Dmax, TV95, and HI of PTV. Furthermore, significant statistical differences were found in the dose parameters for the OARs, namely, V5, V20, and V30 of left lung-GTV, right lung (Dmean), D33, and Dmean of the heart, and Dmax of the spine, respectively. Although statistical differences do exist, the magnitude of the differences is too small to cause any clinically observable effect.

No abstract

Purpose:The aim of this investigation was to measure the gain in DVH indices when the recently developed MLC was used for Cobalt-60 treatments. Methods: A prototype multileaf collimator (MLC) that was retrofitted to telecobalt-60 therapy machine was reported and is currently proposed for clinical trials in our institution. Ten patients' plans that were previously planned through an ECLIPSE ® treatment planning system and were treated with open beams from Cobalt-60 machine were imported into Radiation Oncology Planning System [ROPS] and the dose calculations and dose volume histogram (DVH) analysis were performed. The plans were re-planned using the Cobalt-MLC, a feature available in the ROPS planning system. The DVH analysis consisted of conformity index (CI), homogeneity index (HI) and conformation number (CN). The results of this study are presented in this paper. The analysis specifically aimed at measuring the gain in these indices when the MLC was compared with open beams. Results: DVH Comparison of ten sites using open and Cobalt MLC fields showed that the use of MLC results in reduced normal tissue dose, while maintaining the GTV dose. Lower value of CI for normal structures was observed demonstrating the sparing of critical organs when MLC was used. The index HI was studied to show the significance of hot spots outside the PTV. Hot spots were observed even with MLC beams for some cases due to less number of fields. Conclusion: It has been demonstrated through DVH analysis that the use of the recently developed MLC for Cobalt Teletherapy machine results in benefit for the treatment of patients.

No abstract